ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Brigatinib Tablet Market Insights, Forecast to 2030
Published Date: December 2024
|
Report Code: QYRE-Auto-13E9982
Home | Market Reports | Health| Pharmacy
Global Brigatinib Tablet Market Insights Forecast to 2028
BUY CHAPTERS

Global Brigatinib Tablet Market Insights, Forecast to 2030

Code: QYRE-Auto-13E9982
Report
December 2024
Pages:73
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Takeda

Brigatinib Tablet Market Size

The global Brigatinib Tablet market is projected to grow from US$ 237 million in 2024 to US$ 349.7 million by 2030, at a Compound Annual Growth Rate (CAGR) of 6.7% during the forecast period.

Brigatinib Tablet Market

Brigatinib Tablet Market

Brigatinib Tablet is a cancer medicine that is used to treat adults with a type of lung cancer called non-small cell lung cancer (NSCLC) who have been treated before with a cancer medicine called crizotinib.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers:
This report presents an overview of global market for Brigatinib Tablet, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Brigatinib Tablet, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Brigatinib Tablet, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Brigatinib Tablet sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Brigatinib Tablet market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Brigatinib Tablet sales, projected growth trends, production technology, application and end-user industry.
Market Segmentation

Scope of Brigatinib Tablet Market Report

Report Metric Details
Report Name Brigatinib Tablet Market
Accounted market size in 2024 US$ 237 million
Forecasted market size in 2030 US$ 349.7 million
CAGR 6.7
Base Year 2024
Forecasted years 2025 - 2030
Segment by Type
  • 30mg
  • 50mg
  • 180mg
Segment by Application
  • Hospital
  • Pharmacy
Segment by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Sales (consumption), revenue of Brigatinib Tablet in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 3: Detailed analysis of Brigatinib Tablet manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
  • Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
  • Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Brigatinib Tablet sales, revenue, price, gross margin, and recent development, etc.
  • Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
  • Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 14: The main points and conclusions of the report.

FAQ for this report

How fast is Brigatinib Tablet Market growing?

Ans: The Brigatinib Tablet Market witnessing a CAGR of 6.7 during the forecast period 2025-2030.

What is the Brigatinib Tablet Market size in 2030?

Ans: The Brigatinib Tablet Market size in 2030 will be US$ 349.7 million.

What are the Application segmentation covered in the Brigatinib Tablet Market report?

Ans: The Applications covered in the Brigatinib Tablet Market report are Hospital, Pharmacy

What are the Type segmentation covered in the Brigatinib Tablet Market report?

Ans: The Types covered in the Brigatinib Tablet Market report are 30mg, 50mg, 180mg

1 Study Coverage
1.1 Brigatinib Tablet Product Introduction
1.2 Market by Type
1.2.1 Global Brigatinib Tablet Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 30mg
1.2.3 50mg
1.2.4 180mg
1.3 Market by Application
1.3.1 Global Brigatinib Tablet Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Pharmacy
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Brigatinib Tablet Sales Estimates and Forecasts 2019-2030
2.2 Global Brigatinib Tablet Revenue by Region
2.2.1 Global Brigatinib Tablet Revenue by Region: 2019 VS 2023 VS 2030
2.2.2 Global Brigatinib Tablet Revenue by Region (2019-2024)
2.2.3 Global Brigatinib Tablet Revenue by Region (2025-2030)
2.2.4 Global Brigatinib Tablet Revenue Market Share by Region (2019-2030)
2.3 Global Brigatinib Tablet Sales Estimates and Forecasts 2019-2030
2.4 Global Brigatinib Tablet Sales by Region
2.4.1 Global Brigatinib Tablet Sales by Region: 2019 VS 2023 VS 2030
2.4.2 Global Brigatinib Tablet Sales by Region (2019-2024)
2.4.3 Global Brigatinib Tablet Sales by Region (2025-2030)
2.4.4 Global Brigatinib Tablet Sales Market Share by Region (2019-2030)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Brigatinib Tablet Sales by Manufacturers
3.1.1 Global Brigatinib Tablet Sales by Manufacturers (2019-2024)
3.1.2 Global Brigatinib Tablet Sales Market Share by Manufacturers (2019-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Brigatinib Tablet in 2023
3.2 Global Brigatinib Tablet Revenue by Manufacturers
3.2.1 Global Brigatinib Tablet Revenue by Manufacturers (2019-2024)
3.2.2 Global Brigatinib Tablet Revenue Market Share by Manufacturers (2019-2024)
3.2.3 Global Top 10 and Top 5 Companies by Brigatinib Tablet Revenue in 2023
3.3 Global Key Players of Brigatinib Tablet, Industry Ranking, 2022 VS 2023 VS 2024
3.4 Global Brigatinib Tablet Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Brigatinib Tablet Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Brigatinib Tablet, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Brigatinib Tablet, Product Offered and Application
3.8 Global Key Manufacturers of Brigatinib Tablet, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Brigatinib Tablet Sales by Type
4.1.1 Global Brigatinib Tablet Historical Sales by Type (2019-2024)
4.1.2 Global Brigatinib Tablet Forecasted Sales by Type (2025-2030)
4.1.3 Global Brigatinib Tablet Sales Market Share by Type (2019-2030)
4.2 Global Brigatinib Tablet Revenue by Type
4.2.1 Global Brigatinib Tablet Historical Revenue by Type (2019-2024)
4.2.2 Global Brigatinib Tablet Forecasted Revenue by Type (2025-2030)
4.2.3 Global Brigatinib Tablet Revenue Market Share by Type (2019-2030)
4.3 Global Brigatinib Tablet Price by Type
4.3.1 Global Brigatinib Tablet Price by Type (2019-2024)
4.3.2 Global Brigatinib Tablet Price Forecast by Type (2025-2030)
5 Market Size by Application
5.1 Global Brigatinib Tablet Sales by Application
5.1.1 Global Brigatinib Tablet Historical Sales by Application (2019-2024)
5.1.2 Global Brigatinib Tablet Forecasted Sales by Application (2025-2030)
5.1.3 Global Brigatinib Tablet Sales Market Share by Application (2019-2030)
5.2 Global Brigatinib Tablet Revenue by Application
5.2.1 Global Brigatinib Tablet Historical Revenue by Application (2019-2024)
5.2.2 Global Brigatinib Tablet Forecasted Revenue by Application (2025-2030)
5.2.3 Global Brigatinib Tablet Revenue Market Share by Application (2019-2030)
5.3 Global Brigatinib Tablet Price by Application
5.3.1 Global Brigatinib Tablet Price by Application (2019-2024)
5.3.2 Global Brigatinib Tablet Price Forecast by Application (2025-2030)
6 US & Canada
6.1 US & Canada Brigatinib Tablet Market Size by Type
6.1.1 US & Canada Brigatinib Tablet Sales by Type (2019-2030)
6.1.2 US & Canada Brigatinib Tablet Revenue by Type (2019-2030)
6.2 US & Canada Brigatinib Tablet Market Size by Application
6.2.1 US & Canada Brigatinib Tablet Sales by Application (2019-2030)
6.2.2 US & Canada Brigatinib Tablet Revenue by Application (2019-2030)
6.3 US & Canada Brigatinib Tablet Market Size by Country
6.3.1 US & Canada Brigatinib Tablet Revenue by Country: 2019 VS 2023 VS 2030
6.3.2 US & Canada Brigatinib Tablet Sales by Country (2019-2030)
6.3.3 US & Canada Brigatinib Tablet Revenue by Country (2019-2030)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Brigatinib Tablet Market Size by Type
7.1.1 Europe Brigatinib Tablet Sales by Type (2019-2030)
7.1.2 Europe Brigatinib Tablet Revenue by Type (2019-2030)
7.2 Europe Brigatinib Tablet Market Size by Application
7.2.1 Europe Brigatinib Tablet Sales by Application (2019-2030)
7.2.2 Europe Brigatinib Tablet Revenue by Application (2019-2030)
7.3 Europe Brigatinib Tablet Market Size by Country
7.3.1 Europe Brigatinib Tablet Revenue by Country: 2019 VS 2023 VS 2030
7.3.2 Europe Brigatinib Tablet Sales by Country (2019-2030)
7.3.3 Europe Brigatinib Tablet Revenue by Country (2019-2030)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Brigatinib Tablet Market Size
8.1.1 China Brigatinib Tablet Sales (2019-2030)
8.1.2 China Brigatinib Tablet Revenue (2019-2030)
8.2 China Brigatinib Tablet Market Size by Application
8.2.1 China Brigatinib Tablet Sales by Application (2019-2030)
8.2.2 China Brigatinib Tablet Revenue by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Brigatinib Tablet Market Size by Type
9.1.1 Asia Brigatinib Tablet Sales by Type (2019-2030)
9.1.2 Asia Brigatinib Tablet Revenue by Type (2019-2030)
9.2 Asia Brigatinib Tablet Market Size by Application
9.2.1 Asia Brigatinib Tablet Sales by Application (2019-2030)
9.2.2 Asia Brigatinib Tablet Revenue by Application (2019-2030)
9.3 Asia Brigatinib Tablet Sales by Region
9.3.1 Asia Brigatinib Tablet Revenue by Region: 2019 VS 2023 VS 2030
9.3.2 Asia Brigatinib Tablet Revenue by Region (2019-2030)
9.3.3 Asia Brigatinib Tablet Sales by Region (2019-2030)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Brigatinib Tablet Market Size by Type
10.1.1 Middle East, Africa and Latin America Brigatinib Tablet Sales by Type (2019-2030)
10.1.2 Middle East, Africa and Latin America Brigatinib Tablet Revenue by Type (2019-2030)
10.2 Middle East, Africa and Latin America Brigatinib Tablet Market Size by Application
10.2.1 Middle East, Africa and Latin America Brigatinib Tablet Sales by Application (2019-2030)
10.2.2 Middle East, Africa and Latin America Brigatinib Tablet Revenue by Application (2019-2030)
10.3 Middle East, Africa and Latin America Brigatinib Tablet Sales by Country
10.3.1 Middle East, Africa and Latin America Brigatinib Tablet Revenue by Country: 2019 VS 2023 VS 2030
10.3.2 Middle East, Africa and Latin America Brigatinib Tablet Revenue by Country (2019-2030)
10.3.3 Middle East, Africa and Latin America Brigatinib Tablet Sales by Country (2019-2030)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Takeda
11.1.1 Takeda Company Information
11.1.2 Takeda Overview
11.1.3 Takeda Brigatinib Tablet Sales, Price, Revenue and Gross Margin (2019-2024)
11.1.4 Takeda Brigatinib Tablet Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Takeda Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Brigatinib Tablet Industry Chain Analysis
12.2 Brigatinib Tablet Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Brigatinib Tablet Production Mode & Process
12.4 Brigatinib Tablet Sales and Marketing
12.4.1 Brigatinib Tablet Sales Channels
12.4.2 Brigatinib Tablet Distributors
12.5 Brigatinib Tablet Customers
13 Market Dynamics
13.1 Brigatinib Tablet Industry Trends
13.2 Brigatinib Tablet Market Drivers
13.3 Brigatinib Tablet Market Challenges
13.4 Brigatinib Tablet Market Restraints
14 Key Findings in The Global Brigatinib Tablet Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
FEATURED COMPANIES
Takeda
List of Tables
    Table 1. Global Brigatinib Tablet Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Table 2. Major Manufacturers of 30mg
    Table 3. Major Manufacturers of 50mg
    Table 4. Major Manufacturers of 180mg
    Table 5. Global Brigatinib Tablet Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Table 6. Global Brigatinib Tablet Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 7. Global Brigatinib Tablet Revenue by Region (2019-2024) & (US$ Million)
    Table 8. Global Brigatinib Tablet Revenue by Region (2025-2030) & (US$ Million)
    Table 9. Global Brigatinib Tablet Revenue Market Share by Region (2019-2024)
    Table 10. Global Brigatinib Tablet Revenue Market Share by Region (2025-2030)
    Table 11. Global Brigatinib Tablet Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 12. Global Brigatinib Tablet Sales by Region (2019-2024) & (K Unit)
    Table 13. Global Brigatinib Tablet Sales by Region (2025-2030) & (K Unit)
    Table 14. Global Brigatinib Tablet Sales Market Share by Region (2019-2024)
    Table 15. Global Brigatinib Tablet Sales Market Share by Region (2025-2030)
    Table 16. Global Brigatinib Tablet Sales by Manufacturers (2019-2024) & (K Unit)
    Table 17. Global Brigatinib Tablet Sales Share by Manufacturers (2019-2024)
    Table 18. Global Brigatinib Tablet Revenue by Manufacturers (2019-2024) & (US$ Million)
    Table 19. Global Brigatinib Tablet Revenue Share by Manufacturers (2019-2024)
    Table 20. Global Key Players of Brigatinib Tablet, Industry Ranking, 2022 VS 2023 VS 2024
    Table 21. Brigatinib Tablet Price by Manufacturers 2019-2024 (USD/Unit)
    Table 22. Global Brigatinib Tablet Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 23. Global Brigatinib Tablet by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Brigatinib Tablet as of 2023)
    Table 24. Global Key Manufacturers of Brigatinib Tablet, Manufacturing Base Distribution and Headquarters
    Table 25. Global Key Manufacturers of Brigatinib Tablet, Product Offered and Application
    Table 26. Global Key Manufacturers of Brigatinib Tablet, Date of Enter into This Industry
    Table 27. Mergers & Acquisitions, Expansion Plans
    Table 28. Global Brigatinib Tablet Sales by Type (2019-2024) & (K Unit)
    Table 29. Global Brigatinib Tablet Sales by Type (2025-2030) & (K Unit)
    Table 30. Global Brigatinib Tablet Sales Share by Type (2019-2024)
    Table 31. Global Brigatinib Tablet Sales Share by Type (2025-2030)
    Table 32. Global Brigatinib Tablet Revenue by Type (2019-2024) & (US$ Million)
    Table 33. Global Brigatinib Tablet Revenue by Type (2025-2030) & (US$ Million)
    Table 34. Global Brigatinib Tablet Revenue Share by Type (2019-2024)
    Table 35. Global Brigatinib Tablet Revenue Share by Type (2025-2030)
    Table 36. Brigatinib Tablet Price by Type (2019-2024) & (USD/Unit)
    Table 37. Global Brigatinib Tablet Price Forecast by Type (2025-2030) & (USD/Unit)
    Table 38. Global Brigatinib Tablet Sales by Application (2019-2024) & (K Unit)
    Table 39. Global Brigatinib Tablet Sales by Application (2025-2030) & (K Unit)
    Table 40. Global Brigatinib Tablet Sales Share by Application (2019-2024)
    Table 41. Global Brigatinib Tablet Sales Share by Application (2025-2030)
    Table 42. Global Brigatinib Tablet Revenue by Application (2019-2024) & (US$ Million)
    Table 43. Global Brigatinib Tablet Revenue by Application (2025-2030) & (US$ Million)
    Table 44. Global Brigatinib Tablet Revenue Share by Application (2019-2024)
    Table 45. Global Brigatinib Tablet Revenue Share by Application (2025-2030)
    Table 46. Brigatinib Tablet Price by Application (2019-2024) & (USD/Unit)
    Table 47. Global Brigatinib Tablet Price Forecast by Application (2025-2030) & (USD/Unit)
    Table 48. US & Canada Brigatinib Tablet Sales by Type (2019-2024) & (K Unit)
    Table 49. US & Canada Brigatinib Tablet Sales by Type (2025-2030) & (K Unit)
    Table 50. US & Canada Brigatinib Tablet Revenue by Type (2019-2024) & (US$ Million)
    Table 51. US & Canada Brigatinib Tablet Revenue by Type (2025-2030) & (US$ Million)
    Table 52. US & Canada Brigatinib Tablet Sales by Application (2019-2024) & (K Unit)
    Table 53. US & Canada Brigatinib Tablet Sales by Application (2025-2030) & (K Unit)
    Table 54. US & Canada Brigatinib Tablet Revenue by Application (2019-2024) & (US$ Million)
    Table 55. US & Canada Brigatinib Tablet Revenue by Application (2025-2030) & (US$ Million)
    Table 56. US & Canada Brigatinib Tablet Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 57. US & Canada Brigatinib Tablet Revenue by Country (2019-2024) & (US$ Million)
    Table 58. US & Canada Brigatinib Tablet Revenue by Country (2025-2030) & (US$ Million)
    Table 59. US & Canada Brigatinib Tablet Sales by Country (2019-2024) & (K Unit)
    Table 60. US & Canada Brigatinib Tablet Sales by Country (2025-2030) & (K Unit)
    Table 61. Europe Brigatinib Tablet Sales by Type (2019-2024) & (K Unit)
    Table 62. Europe Brigatinib Tablet Sales by Type (2025-2030) & (K Unit)
    Table 63. Europe Brigatinib Tablet Revenue by Type (2019-2024) & (US$ Million)
    Table 64. Europe Brigatinib Tablet Revenue by Type (2025-2030) & (US$ Million)
    Table 65. Europe Brigatinib Tablet Sales by Application (2019-2024) & (K Unit)
    Table 66. Europe Brigatinib Tablet Sales by Application (2025-2030) & (K Unit)
    Table 67. Europe Brigatinib Tablet Revenue by Application (2019-2024) & (US$ Million)
    Table 68. Europe Brigatinib Tablet Revenue by Application (2025-2030) & (US$ Million)
    Table 69. Europe Brigatinib Tablet Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 70. Europe Brigatinib Tablet Revenue by Country (2019-2024) & (US$ Million)
    Table 71. Europe Brigatinib Tablet Revenue by Country (2025-2030) & (US$ Million)
    Table 72. Europe Brigatinib Tablet Sales by Country (2019-2024) & (K Unit)
    Table 73. Europe Brigatinib Tablet Sales by Country (2025-2030) & (K Unit)
    Table 74. China Brigatinib Tablet Sales by Type (2019-2024) & (K Unit)
    Table 75. China Brigatinib Tablet Sales by Type (2025-2030) & (K Unit)
    Table 76. China Brigatinib Tablet Revenue by Type (2019-2024) & (US$ Million)
    Table 77. China Brigatinib Tablet Revenue by Type (2025-2030) & (US$ Million)
    Table 78. China Brigatinib Tablet Sales by Application (2019-2024) & (K Unit)
    Table 79. China Brigatinib Tablet Sales by Application (2025-2030) & (K Unit)
    Table 80. China Brigatinib Tablet Revenue by Application (2019-2024) & (US$ Million)
    Table 81. China Brigatinib Tablet Revenue by Application (2025-2030) & (US$ Million)
    Table 82. Asia Brigatinib Tablet Sales by Type (2019-2024) & (K Unit)
    Table 83. Asia Brigatinib Tablet Sales by Type (2025-2030) & (K Unit)
    Table 84. Asia Brigatinib Tablet Revenue by Type (2019-2024) & (US$ Million)
    Table 85. Asia Brigatinib Tablet Revenue by Type (2025-2030) & (US$ Million)
    Table 86. Asia Brigatinib Tablet Sales by Application (2019-2024) & (K Unit)
    Table 87. Asia Brigatinib Tablet Sales by Application (2025-2030) & (K Unit)
    Table 88. Asia Brigatinib Tablet Revenue by Application (2019-2024) & (US$ Million)
    Table 89. Asia Brigatinib Tablet Revenue by Application (2025-2030) & (US$ Million)
    Table 90. Asia Brigatinib Tablet Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 91. Asia Brigatinib Tablet Revenue by Region (2019-2024) & (US$ Million)
    Table 92. Asia Brigatinib Tablet Revenue by Region (2025-2030) & (US$ Million)
    Table 93. Asia Brigatinib Tablet Sales by Region (2019-2024) & (K Unit)
    Table 94. Asia Brigatinib Tablet Sales by Region (2025-2030) & (K Unit)
    Table 95. Middle East, Africa and Latin America Brigatinib Tablet Sales by Type (2019-2024) & (K Unit)
    Table 96. Middle East, Africa and Latin America Brigatinib Tablet Sales by Type (2025-2030) & (K Unit)
    Table 97. Middle East, Africa and Latin America Brigatinib Tablet Revenue by Type (2019-2024) & (US$ Million)
    Table 98. Middle East, Africa and Latin America Brigatinib Tablet Revenue by Type (2025-2030) & (US$ Million)
    Table 99. Middle East, Africa and Latin America Brigatinib Tablet Sales by Application (2019-2024) & (K Unit)
    Table 100. Middle East, Africa and Latin America Brigatinib Tablet Sales by Application (2025-2030) & (K Unit)
    Table 101. Middle East, Africa and Latin America Brigatinib Tablet Revenue by Application (2019-2024) & (US$ Million)
    Table 102. Middle East, Africa and Latin America Brigatinib Tablet Revenue by Application (2025-2030) & (US$ Million)
    Table 103. Middle East, Africa and Latin America Brigatinib Tablet Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 104. Middle East, Africa and Latin America Brigatinib Tablet Revenue by Country (2019-2024) & (US$ Million)
    Table 105. Middle East, Africa and Latin America Brigatinib Tablet Revenue by Country (2025-2030) & (US$ Million)
    Table 106. Middle East, Africa and Latin America Brigatinib Tablet Sales by Country (2019-2024) & (K Unit)
    Table 107. Middle East, Africa and Latin America Brigatinib Tablet Sales by Country (2025-2030) & (K Unit)
    Table 108. Takeda Company Information
    Table 109. Takeda Description and Major Businesses
    Table 110. Takeda Brigatinib Tablet Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 111. Takeda Brigatinib Tablet Product Model Numbers, Pictures, Descriptions and Specifications
    Table 112. Takeda Recent Developments
    Table 113. Key Raw Materials Lists
    Table 114. Raw Materials Key Suppliers Lists
    Table 115. Brigatinib Tablet Distributors List
    Table 116. Brigatinib Tablet Customers List
    Table 117. Brigatinib Tablet Market Trends
    Table 118. Brigatinib Tablet Market Drivers
    Table 119. Brigatinib Tablet Market Challenges
    Table 120. Brigatinib Tablet Market Restraints
    Table 121. Research Programs/Design for This Report
    Table 122. Key Data Information from Secondary Sources
    Table 123. Key Data Information from Primary Sources
List of Figures
    Figure 1. Brigatinib Tablet Product Picture
    Figure 2. Global Brigatinib Tablet Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Brigatinib Tablet Market Share by Type in 2023 & 2030
    Figure 4. 30mg Product Picture
    Figure 5. 50mg Product Picture
    Figure 6. 180mg Product Picture
    Figure 7. Global Brigatinib Tablet Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 8. Global Brigatinib Tablet Market Share by Application in 2023 & 2030
    Figure 9. Hospital
    Figure 10. Pharmacy
    Figure 11. Brigatinib Tablet Report Years Considered
    Figure 12. Global Brigatinib Tablet Revenue, (US$ Million), 2019 VS 2023 VS 2030
    Figure 13. Global Brigatinib Tablet Revenue 2019-2030 (US$ Million)
    Figure 14. Global Brigatinib Tablet Revenue Market Share by Region in Percentage: 2023 Versus 2030
    Figure 15. Global Brigatinib Tablet Revenue Market Share by Region (2019-2030)
    Figure 16. Global Brigatinib Tablet Sales 2019-2030 ((K Unit)
    Figure 17. Global Brigatinib Tablet Sales Market Share by Region (2019-2030)
    Figure 18. US & Canada Brigatinib Tablet Sales YoY (2019-2030) & (K Unit)
    Figure 19. US & Canada Brigatinib Tablet Revenue YoY (2019-2030) & (US$ Million)
    Figure 20. Europe Brigatinib Tablet Sales YoY (2019-2030) & (K Unit)
    Figure 21. Europe Brigatinib Tablet Revenue YoY (2019-2030) & (US$ Million)
    Figure 22. China Brigatinib Tablet Sales YoY (2019-2030) & (K Unit)
    Figure 23. China Brigatinib Tablet Revenue YoY (2019-2030) & (US$ Million)
    Figure 24. Asia (excluding China) Brigatinib Tablet Sales YoY (2019-2030) & (K Unit)
    Figure 25. Asia (excluding China) Brigatinib Tablet Revenue YoY (2019-2030) & (US$ Million)
    Figure 26. Middle East, Africa and Latin America Brigatinib Tablet Sales YoY (2019-2030) & (K Unit)
    Figure 27. Middle East, Africa and Latin America Brigatinib Tablet Revenue YoY (2019-2030) & (US$ Million)
    Figure 28. The Brigatinib Tablet Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023
    Figure 29. The Top 5 and 10 Largest Manufacturers of Brigatinib Tablet in the World: Market Share by Brigatinib Tablet Revenue in 2023
    Figure 30. Global Brigatinib Tablet Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 31. Global Brigatinib Tablet Sales Market Share by Type (2019-2030)
    Figure 32. Global Brigatinib Tablet Revenue Market Share by Type (2019-2030)
    Figure 33. Global Brigatinib Tablet Sales Market Share by Application (2019-2030)
    Figure 34. Global Brigatinib Tablet Revenue Market Share by Application (2019-2030)
    Figure 35. US & Canada Brigatinib Tablet Sales Market Share by Type (2019-2030)
    Figure 36. US & Canada Brigatinib Tablet Revenue Market Share by Type (2019-2030)
    Figure 37. US & Canada Brigatinib Tablet Sales Market Share by Application (2019-2030)
    Figure 38. US & Canada Brigatinib Tablet Revenue Market Share by Application (2019-2030)
    Figure 39. US & Canada Brigatinib Tablet Revenue Share by Country (2019-2030)
    Figure 40. US & Canada Brigatinib Tablet Sales Share by Country (2019-2030)
    Figure 41. U.S. Brigatinib Tablet Revenue (2019-2030) & (US$ Million)
    Figure 42. Canada Brigatinib Tablet Revenue (2019-2030) & (US$ Million)
    Figure 43. Europe Brigatinib Tablet Sales Market Share by Type (2019-2030)
    Figure 44. Europe Brigatinib Tablet Revenue Market Share by Type (2019-2030)
    Figure 45. Europe Brigatinib Tablet Sales Market Share by Application (2019-2030)
    Figure 46. Europe Brigatinib Tablet Revenue Market Share by Application (2019-2030)
    Figure 47. Europe Brigatinib Tablet Revenue Share by Country (2019-2030)
    Figure 48. Europe Brigatinib Tablet Sales Share by Country (2019-2030)
    Figure 49. Germany Brigatinib Tablet Revenue (2019-2030) & (US$ Million)
    Figure 50. France Brigatinib Tablet Revenue (2019-2030) & (US$ Million)
    Figure 51. U.K. Brigatinib Tablet Revenue (2019-2030) & (US$ Million)
    Figure 52. Italy Brigatinib Tablet Revenue (2019-2030) & (US$ Million)
    Figure 53. Russia Brigatinib Tablet Revenue (2019-2030) & (US$ Million)
    Figure 54. China Brigatinib Tablet Sales Market Share by Type (2019-2030)
    Figure 55. China Brigatinib Tablet Revenue Market Share by Type (2019-2030)
    Figure 56. China Brigatinib Tablet Sales Market Share by Application (2019-2030)
    Figure 57. China Brigatinib Tablet Revenue Market Share by Application (2019-2030)
    Figure 58. Asia Brigatinib Tablet Sales Market Share by Type (2019-2030)
    Figure 59. Asia Brigatinib Tablet Revenue Market Share by Type (2019-2030)
    Figure 60. Asia Brigatinib Tablet Sales Market Share by Application (2019-2030)
    Figure 61. Asia Brigatinib Tablet Revenue Market Share by Application (2019-2030)
    Figure 62. Asia Brigatinib Tablet Revenue Share by Region (2019-2030)
    Figure 63. Asia Brigatinib Tablet Sales Share by Region (2019-2030)
    Figure 64. Japan Brigatinib Tablet Revenue (2019-2030) & (US$ Million)
    Figure 65. South Korea Brigatinib Tablet Revenue (2019-2030) & (US$ Million)
    Figure 66. China Taiwan Brigatinib Tablet Revenue (2019-2030) & (US$ Million)
    Figure 67. Southeast Asia Brigatinib Tablet Revenue (2019-2030) & (US$ Million)
    Figure 68. India Brigatinib Tablet Revenue (2019-2030) & (US$ Million)
    Figure 69. Middle East, Africa and Latin America Brigatinib Tablet Sales Market Share by Type (2019-2030)
    Figure 70. Middle East, Africa and Latin America Brigatinib Tablet Revenue Market Share by Type (2019-2030)
    Figure 71. Middle East, Africa and Latin America Brigatinib Tablet Sales Market Share by Application (2019-2030)
    Figure 72. Middle East, Africa and Latin America Brigatinib Tablet Revenue Market Share by Application (2019-2030)
    Figure 73. Middle East, Africa and Latin America Brigatinib Tablet Revenue Share by Country (2019-2030)
    Figure 74. Middle East, Africa and Latin America Brigatinib Tablet Sales Share by Country (2019-2030)
    Figure 75. Brazil Brigatinib Tablet Revenue (2019-2030) & (US$ Million)
    Figure 76. Mexico Brigatinib Tablet Revenue (2019-2030) & (US$ Million)
    Figure 77. Turkey Brigatinib Tablet Revenue (2019-2030) & (US$ Million)
    Figure 78. Israel Brigatinib Tablet Revenue (2019-2030) & (US$ Million)
    Figure 79. GCC Countries Brigatinib Tablet Revenue (2019-2030) & (US$ Million)
    Figure 80. Brigatinib Tablet Value Chain
    Figure 81. Brigatinib Tablet Production Process
    Figure 82. Channels of Distribution
    Figure 83. Distributors Profiles
    Figure 84. Bottom-up and Top-down Approaches for This Report
    Figure 85. Data Triangulation
    Figure 86. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SecuX Technology Inc

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Brigatinib Tablet Market Insights, Forecast to 2030

120 Pages
Type: Report
Code: QYRE-Auto-13E9982
Fri Dec 27 00:00:00 UTC 2024

Add to Cart

Global Durezol Market Insights, Forecast to 2030

120 Pages
Type: Report
Code: QYRE-Auto-22W864
Fri Dec 27 00:00:00 UTC 2024

Add to Cart

Global Rats Model Services Market Insights, Forecast to 2030

120 Pages
Type: Report
Code: QYRE-Auto-39V834
Fri Dec 27 00:00:00 UTC 2024

Add to Cart

Global Argininemia Drugs Market Insights, Forecast to 2030

120 Pages
Type: Report
Code: QYRE-Auto-11E9950
Fri Dec 27 00:00:00 UTC 2024

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions